Document is current
Any future updates will be listed below
-
Authors
Larrosa-Godall, Mireia
Ang, Joshua X. D.
Leftwich, Philip T.
Gonzalez, Estela
Shackleford, Lewis
Nevard, Katherine
Noad, Rob
Anderson, Michelle A. E.
Alphey, Luke
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation, United States (INV-008549)
Biotechnology and Biological Sciences Research Council (BBS/E/I/00007033, BBS/E/I/00007038, and BBS/E/I/00007039)
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 26 January 2025
First Online: 7 February 2025
Declarations
:
: All work carried out in this study was approved by the Biological Agents and Genetic Modification Safety Committee (BAGMSC) at The Pirbright Institute and the Biological Agents Safety Committee (BASC) at the University of York in accordance with all relevant regulations.
: Not applicable.
: LA is an adviser to Synvect Inc. and Biocentis Ltd., with equity and/or financial interest in those companies. The other authors declare that they have no competing interests.
